Fig. 2From: Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patientsSummary of outcomes after neoadjuvant therapy among resectable, borderline resectable, and locally advanced unresectable patients with pancreatic adenocarcinomaBack to article page